Federico Innocenti

19PUBLICATIONS
46CO-AUTHORS
Ngā matatika o te Māori (Māori ethics)Cardiovascular medicine and haematology not elsewhere classifiedOncology and carcinogenesis not elsewhere classifiedMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 30, 2024
Reply to A. Sartore-Bianchi et al.

Francesca Battaglin, Fang-Shu Ou, Federico Innocenti

|Jul 11, 2024
Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension.

Julia C F Quintanilha, William Kevin Kelly, Federico Innocenti

|Mar 08, 2024
HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.

Francesca Battaglin, Fang-Shu Ou, Xueping Qu

|Feb 16, 2024
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.

Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon

|Feb 12, 2024
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model.

Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik

|Nov 22, 2023
DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations.

Federico Innocenti, Wancen Mu, Xueping Qu

Pageof 4

Frequent Collaborators

6 joint publications

Alan P Venook

6 joint publications

Fang-Shu Ou

5 joint publications

Heinz-Josef Lenz

3 joint publications

Julia C F Quintanilha